Expression of vascular endothelial growth factor receptors in human prostate cancer

Urology

Volumn 54, Issue 3, 1999, Pages 567-572

  Ferrer, Fernando A ^b   Miller, Lauri J ^b   Lindquist, Richard ^b   Kowalczyk, Pamela ^b   Laudone, Vincent P ^b   Albertsen, Peter C ^b   Kreutzer, Donald L ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FETAL LIVER KINASE 1; FMS LIKE TYROSINE KINASE 1; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR VASCULARIZATION;

ENDOTHELIUM, VASCULAR; HUMANS; MALE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 0032838197     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00156-9     Document Type: Article

References (23)

1. Bigler SA, Deering RE, and Brawer MK: Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 24: 220-226, 1993.
2. Weidner N: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409, 1993.
3. Ferrer FA, Miller LJ, Andrawis RI, et al: Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J Urol 157: 2329-2333, 1997.
4. Connolly JM, and Rose DP: Angiogenesis in two human prostate cancer cell lines with differing metastatic potential when growing as solid tumors in nude mice. J Urol 160: 932-936, 1998.
5. Risau W: What, if anything, is an angiogenic factor? Cancer Metast Rev 15: 149-151, 1996.
6. Claffey KP, and Robinson GS: Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metast Rev 15: 165-176, 1996.
7. Dvorak HF, Brown LF, Detmer M, et al: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
8. Liu B, Earl HM, Baban D, et al: Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochem Biophys Res Commun 17: 721-727, 1995.
9. Masood R, Cai J, Zheng T, et al: Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci 94: 979-984, 1997.
10. Terman BI, and Dougher-Vermazen M: Biological properties of VEGF/VPF receptors. Cancer Metast Rev 15: 159-163, 1996.
11. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
12. Chevalier S: Commentary on prostatic neovascularization and vascular endothelial growth factor. J Urol 157: 2040-2041, 1997.
13. Waltenberger J, Claesson-Welsh L, Siegnahn A, et al: Different signal transduction properties of KDR and FLT1, two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988-26995, 1994.
14. Dougher-Vermazen M, Holmes J, Bohlen P, et al: Biological activity of autophosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF receptor. Biochem Biophys Res Commun 205: 728-738, 1994.
15. Seetharam L, Gotoh N, Maru Y, et al: A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor. Oncogene 10: 135-147, 1995.
16. Cunningham SA, Waxham MN, Arrate PM, et al: Interaction of the FLT-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 270: 20254-20257, 1995.
17. Takahashi Y, Kitadai Y, Bucana CD, et al: Expression of vascular endothelial growth factor and its receptor KDR, correlated with vascularity, metastasis, and proliferation in human colon cancer. Cancer Res 55: 3964-3968, 1995.
18. Warren RS, Yuan H, Matli MR, et al: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789-1797, 1995.
19. Takanami I, Tanaka F, Hashizume T, et al: Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res 12: 2811-2814, 1997.
20. Millauer B, Shawver LK, Plate KH, et al: Glioblastoma growth inhibited in vivo by a dominant negative FLK1 mutant. Nature 367: 576-579, 1994.
21. Kim J, Li B, Winer J, et al: Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo. Nature 262: 841-844, 1993.
22. Boocock C, Charnock-Jones S, Sharkey AM, et al: Expression of vascular endothelial growth factor and its receptors FLT and KDR in ovarian carcinoma. J Natl Cancer Inst 87: 506-516, 1995.
23. Brown LF, Berse B, Jackman RW, et al: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143: 1255-1262, 1995.